|
Investor Information
Vyteris to Present at Rodman & Renshaw Annual Global Investment Conference 09.07.10
FAIR LAWN, NJ, Sep 07, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), manufacturer of the first FDA-approved active patch transdermal drug delivery system and a leader in active transdermal drug delivery technology, today announced that President and Chief Executive Officer Haro Hartounian, Ph.D. will present at the Rodma...
Vyteris and Georgia Tech Enter Into Exclusive Agreement for Transdermal Drug Delivery Technologies 08.24.10
FAIR LAWN, NJ, Aug 24, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), developer of the first FDA-approved active transdermal patch and a leader in alternative drug delivery technology, today announced an agreement with the Georgia Tech Research Corporation of the Georgia Institute of Technology (Georgia Tech) granting Vyt...
Financial Results
|
|
| Delayed 20 minutes. |
| Last Trade: |
0.65 |
| Change: |
0.00
|
| % Change: |
0.000%
|
| Intraday Range: |
0.25 - 0.65 |
| Sep 3, 2010 3:54 PM ET |
| Stock Information >> |
|
|
|
